NEUROPACE INC. - COMMON STOCK

11.95

13-January-25 14:41:40

15 minutes delayed

Stocks

+0.01

+0.08%

Today's range

11.86 - 12.60

ISIN

N/A

Source

NASDAQ

NeuroPace Announces Addition of Lisa Andrade to the Board

19 Oct 2021 16:03:00 By Nasdaq GlobeNewswire
NeuroPace to Participate in Upcoming Conferences

23 Aug 2021 16:03:00 By Nasdaq GlobeNewswire
NeuroPace Reports Second Quarter 2021 Financial Results

12 Aug 2021 16:03:00 By Nasdaq GlobeNewswire
NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021

22 Jul 2021 16:03:00 By Nasdaq GlobeNewswire
NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome

30 Jun 2021 08:00:00 By Nasdaq GlobeNewswire
NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

03 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

20 May 2021 08:00:01 By Nasdaq GlobeNewswire
NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

26 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.